Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
SourceJournal of Hepatology, 70, 3, (2019), pp. 483-493
Article / Letter to editor
Display more detailsDisplay less details
Journal of Hepatology
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.